Portfolio BioGeneration Ventures I

Arcarios B.V. www.arcarios.com

Location Rotterdam (The Netherlands), Diepenbeek (Belgium)
Fund BioGeneration Ventures B.V.
Year 2010
Satus Divested
Arcarios develops novel therapeutics for bone and joint diseases.

arGEN-X B.V. www.argen-x.com

Location Rotterdam (The Netherlands), Gent (Belgium)
Fund BioGeneration Ventures B.V.
Year 2009
Satus Realized
arGEN-X employs a superior therapeutic antibody platform for the generation of human monoclonal antibodies.

BioCeros B.V. www.bioceros.com

Location Utrecht (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2008
Satus Realized
Bioceros offers cell line generation services related to the preclinical development of monoclonal antibodies and generation of GMP-ready protein producing cell lines.

EPD-vision B.V. www.epd-vision.nl

Location Leiden (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2009
Satus Active
EPD-vision makes an integrated software solution available for cardiologists developed at the department of cardiology of the LUMC, Leiden.

FlexGen B.V.

Location Leiden (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2009
Satus Divested
Flexgen develops novel aptamer compounds based on its proprietary flexible array technology.

Lanthio Pharma B.V. www.lanthiopharma.com

Location Groningen (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2012
Satus Realized
Lanthio Pharma discovers and develops Lanthiopeptides, a new class of peptides with high target selectivity and improved "drug-like" properties.

Medisse B.V. 

Location Ede (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2009
Satus Divested
Medisse is developing an array of resorbable implants based on its proprietary PTMC – polymer platform.

Mucosis B.V. www.mucosis.com

Location Groningen (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2007
Satus Active
Mucosis is developing innovative mucosal vaccines that can be applied needle-free via the nose or mouth.

NovioGendix 

Location Nijmegen (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2007
Satus Realized
NovioGendix is developing a new biomarker panel for the detection and management of prostate cancer and other cancers.

Progentix Orthobiology B.V. www.progentix.com

Location Bilthoven (The Netherlands)
Fund BioGeneration Ventures B.V.
Year 2008
Satus Realized
Progentix Orthobiology is developing synthetic bone substitutes designed to accelerate bone healing through a novel micro-structure.
Desktop versie